Babies' Pain Relievers are Safe, Study Finds

Topic: Health

A new study in New Zealand found that acetaminophen and ibuprofen do not increase the risk of eczema or bronchiolitis in babies. The study followed almost 4,000 babies from birth.

Researchers at the University of Auckland conducted a major study to see if using pain relievers like acetaminophen (Tylenol) and ibuprofen (Advil) during a baby's first year increases the risk of eczema or bronchiolitis. These conditions are common in young children, but earlier studies had raised concerns that these medicines might be connected to them.

The study involved almost 4,000 babies from birth across New Zealand. Half were given acetaminophen when they needed it for fever or pain, and the other half were given ibuprofen. The researchers asked parents about their children's health at regular points throughout the study and reviewed prescription information and hospital records.

The results showed that there was no significant difference in the number of babies who developed eczema or bronchiolitis between the two groups. In fact, only 16% of babies in the acetaminophen group developed eczema, compared to 15% in the ibuprofen group. Bronchiolitis affected about 5% of children in each group.

The researchers found that these medicines are safe to use during infancy and do not increase the risk of eczema or bronchiolitis.

Why It Matters

This study is important for parents and healthcare professionals in India because it provides reassurance about using common pain relievers in babies. It also highlights the importance of conducting rigorous research to understand the effects of medicines on children's health.

Key Facts

• The study followed almost 4,000 babies from birth across New Zealand.
• Half of the babies were given acetaminophen and half were given ibuprofen when they needed it for fever or pain.
• There was no significant difference in the number of babies who developed eczema or bronchiolitis between the two groups.
• The study found that both medicines are safe to use during infancy and do not increase the risk of eczema or bronchiolitis.
• The research team plans to publish results from the children at age three, followed by additional findings when they reach age six.

Key Terms

Acetaminophen

A common pain reliever also known as Tylenol

Ibuprofen

A common pain reliever also known as Advil

Implications

This study is important for parents and healthcare professionals in India because it provides reassurance about using common pain relievers in babies. It also highlights the importance of conducting rigorous research to understand the effects of medicines on children's health.